Table 2 Distribution of Charlson co-morbidity score per MME dosage groups
Score | < 50 MME | 50 to 90 MME | > = 90 MME | p-value |
|---|---|---|---|---|
.00 | 304,282 (37.2%) | 311 (17.5%) | 208 (16.6%) | < 0.001 |
1.00 | 190,309 (23.3%) | 351 (19.7%) | 251 (20%) | |
2.00 | 113,691 (13.9%) | 324 (18.2%) | 196 (15.6%) | |
3.00 | 70,125 (8.6%) | 222 (12.5%) | 172 (13.7%) | |
4.00 | 46,378 (5.7%) | 184 (10.3%) | 114 (9.1%) | |
5.00 | 32,295 (4%) | 107 (6%) | 101 (8%) | |
6.00 | 23,290 (2.9%) | 98 (5.5%) | 71 (5.7%) | |
7.00 | 16,312 (2%) | 73 (4.1%) | 60 (4.8%) | |
8.00 | 10,342 (1.3%) | 50 (2.8%) | 35 (2.8%) | |
9.00 | 5729 (0.7%) | 33 (1.9%) | 27 (2.1%) | |
10.00 | 2700 (0.3%) | 12 (0.7%) | 14 (1.1%) | |
11.00 | 1118 (0.1%) | 11 (0.6%) | 5 (0.4%) | |
12.00 | 396 (0%) | 2 (0.1%) | 2 (0.2%) | |
13.00 | 102 (0%) | 0 (0%) | 0 (0%) | |
14.00 | 22 (0%) | 0 (0%) | 0 (0%) | |
15.00 | 5 (0%) | 0 (0%) | 0 (0%) | |
> 17.00 | 1 (0%) | 0 (0%) | 0 (0%) |